Plaque volume, composition, and fraction versus ischemia and outcomes in patients with coronary artery disease

Jurrien H Kuneman1, Inge J van den Hoogen1, Jussi Schultz2

  • 1Department of Cardiology, Leiden University Medical Center, the Netherlands.

Insights

Larger plaque volumes in coronary artery disease (CAD) patients indicate worse outcomes. However, the proportion of non-calcified plaque does not predict adverse events, suggesting total plaque burden is key for risk assessment.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Radiology

Background:

  • Plaque components in coronary artery disease (CAD) are linked to ischemia and patient outcomes.
  • The prognostic value of non-calcified plaque volume fraction in CAD requires further investigation.

Purpose of the Study:

  • To determine if the fraction of non-calcified plaque volume (PV) relative to total PV predicts ischemia and clinical outcomes in CAD patients.
  • To assess the clinical utility of plaque component ratios for outcome prediction.

Main Methods:

  • Quantitative analysis of plaque components from coronary computed tomography angiography in 494 patients with suspected CAD.
  • Positron emission tomography perfusion imaging was used to assess myocardial perfusion.
  • Clinical outcomes, including mortality and myocardial infarction, were tracked during follow-up.

Main Results:

  • Higher total PV and all plaque components were significantly larger in patients with reduced myocardial perfusion.
  • Patients with plaque components exceeding the median experienced worse outcomes (log-rank p < 0.001).
  • Low-attenuation plaque above the median independently predicted worse outcomes (adjusted HR: 2.754, p = 0.045), but plaque fractions did not show prognostic value.

Conclusions:

  • Increased total plaque volume and the presence of any plaque component are associated with abnormal myocardial perfusion and adverse events in CAD patients.
  • The proportion of different plaque components relative to total PV does not offer additional prognostic information beyond overall plaque burden.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
19
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
30
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
22